Global Biomarker Testing Market Growth (Status and Outlook) 2022-2028
- LP 4835167
- 62 Pages
- February 2022
- Pharmaceuticals
The United States Biomarker Testing market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Biomarker Testing market, reaching US$ million by the year 2028. As for the Europe Biomarker Testing landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Biomarker Testing players cover Agilent Technologies, Roche, , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Biomarker Testing market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Sepsis Biomarkers
Antibiotic Resistance Biomarkers
Traumatic Brain Injury (TBI) Testing Biomarkers
Stroke Testing Biomarkers
Antibiotic Stewardship Biomarkers
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital
Diagnostic Center
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Agilent Technologies
Roche
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biomarker Testing Market Size 2017-2028
2.1.2 Biomarker Testing Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Biomarker Testing Segment by Type
2.2.1 Sepsis Biomarkers
2.2.2 Antibiotic Resistance Biomarkers
2.2.3 Traumatic Brain Injury (TBI) Testing Biomarkers
2.2.4 Stroke Testing Biomarkers
2.2.5 Antibiotic Stewardship Biomarkers
2.2.6 Others
2.3 Biomarker Testing Market Size by Type
2.3.1 Biomarker Testing Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Biomarker Testing Market Size Market Share by Type (2017-2022)
2.4 Biomarker Testing Segment by Application
2.4.1 Hospital
2.4.2 Diagnostic Center
2.4.3 Others
2.5 Biomarker Testing Market Size by Application
2.5.1 Biomarker Testing Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Biomarker Testing Market Size Market Share by Application (2017-2022)
3 Biomarker Testing Market Size by Player
3.1 Biomarker Testing Market Size Market Share by Players
3.1.1 Global Biomarker Testing Revenue by Players (2020-2022)
3.1.2 Global Biomarker Testing Revenue Market Share by Players (2020-2022)
3.2 Global Biomarker Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Biomarker Testing by Regions
4.1 Biomarker Testing Market Size by Regions (2017-2022)
4.2 Americas Biomarker Testing Market Size Growth (2017-2022)
4.3 APAC Biomarker Testing Market Size Growth (2017-2022)
4.4 Europe Biomarker Testing Market Size Growth (2017-2022)
4.5 Middle East & Africa Biomarker Testing Market Size Growth (2017-2022)
5 Americas
5.1 Americas Biomarker Testing Market Size by Country (2017-2022)
5.2 Americas Biomarker Testing Market Size by Type (2017-2022)
5.3 Americas Biomarker Testing Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biomarker Testing Market Size by Region (2017-2022)
6.2 APAC Biomarker Testing Market Size by Type (2017-2022)
6.3 APAC Biomarker Testing Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Biomarker Testing by Country (2017-2022)
7.2 Europe Biomarker Testing Market Size by Type (2017-2022)
7.3 Europe Biomarker Testing Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Biomarker Testing by Region (2017-2022)
8.2 Middle East & Africa Biomarker Testing Market Size by Type (2017-2022)
8.3 Middle East & Africa Biomarker Testing Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Biomarker Testing Market Forecast
10.1 Global Biomarker Testing Forecast by Regions (2023-2028)
10.1.1 Global Biomarker Testing Forecast by Regions (2023-2028)
10.1.2 Americas Biomarker Testing Forecast
10.1.3 APAC Biomarker Testing Forecast
10.1.4 Europe Biomarker Testing Forecast
10.1.5 Middle East & Africa Biomarker Testing Forecast
10.2 Americas Biomarker Testing Forecast by Country (2023-2028)
10.2.1 United States Biomarker Testing Market Forecast
10.2.2 Canada Biomarker Testing Market Forecast
10.2.3 Mexico Biomarker Testing Market Forecast
10.2.4 Brazil Biomarker Testing Market Forecast
10.3 APAC Biomarker Testing Forecast by Region (2023-2028)
10.3.1 China Biomarker Testing Market Forecast
10.3.2 Japan Biomarker Testing Market Forecast
10.3.3 Korea Biomarker Testing Market Forecast
10.3.4 Southeast Asia Biomarker Testing Market Forecast
10.3.5 India Biomarker Testing Market Forecast
10.3.6 Australia Biomarker Testing Market Forecast
10.4 Europe Biomarker Testing Forecast by Country (2023-2028)
10.4.1 Germany Biomarker Testing Market Forecast
10.4.2 France Biomarker Testing Market Forecast
10.4.3 UK Biomarker Testing Market Forecast
10.4.4 Italy Biomarker Testing Market Forecast
10.4.5 Russia Biomarker Testing Market Forecast
10.5 Middle East & Africa Biomarker Testing Forecast by Region (2023-2028)
10.5.1 Egypt Biomarker Testing Market Forecast
10.5.2 South Africa Biomarker Testing Market Forecast
10.5.3 Israel Biomarker Testing Market Forecast
10.5.4 Turkey Biomarker Testing Market Forecast
10.5.5 GCC Countries Biomarker Testing Market Forecast
10.6 Global Biomarker Testing Forecast by Type (2023-2028)
10.7 Global Biomarker Testing Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Information
11.1.2 Agilent Technologies Biomarker Testing Product Offered
11.1.3 Agilent Technologies Biomarker Testing Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Agilent Technologies Main Business Overview
11.1.5 Agilent Technologies Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Biomarker Testing Product Offered
11.2.3 Roche Biomarker Testing Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
12 Research Findings and Conclusion
Table 1. Biomarker Testing Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Sepsis Biomarkers
Table 3. Major Players of Antibiotic Resistance Biomarkers
Table 4. Major Players of Traumatic Brain Injury (TBI) Testing Biomarkers
Table 5. Major Players of Stroke Testing Biomarkers
Table 6. Major Players of Antibiotic Stewardship Biomarkers
Table 7. Major Players of Others
Table 8. Biomarker Testing Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Biomarker Testing Market Size by Type (2017-2022) & ($ Millions)
Table 10. Global Biomarker Testing Market Size Market Share by Type (2017-2022)
Table 11. Biomarker Testing Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 12. Global Biomarker Testing Market Size by Application (2017-2022) & ($ Millions)
Table 13. Global Biomarker Testing Market Size Market Share by Application (2017-2022)
Table 14. Global Biomarker Testing Revenue by Players (2020-2022) & ($ Millions)
Table 15. Global Biomarker Testing Revenue Market Share by Player (2020-2022)
Table 16. Biomarker Testing Key Players Head office and Products Offered
Table 17. Biomarker Testing Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Biomarker Testing Market Size by Regions 2017-2022 & ($ Millions)
Table 21. Global Biomarker Testing Market Size Market Share by Regions (2017-2022)
Table 22. Americas Biomarker Testing Market Size by Country (2017-2022) & ($ Millions)
Table 23. Americas Biomarker Testing Market Size Market Share by Country (2017-2022)
Table 24. Americas Biomarker Testing Market Size by Type (2017-2022) & ($ Millions)
Table 25. Americas Biomarker Testing Market Size Market Share by Type (2017-2022)
Table 26. Americas Biomarker Testing Market Size by Application (2017-2022) & ($ Millions)
Table 27. Americas Biomarker Testing Market Size Market Share by Application (2017-2022)
Table 28. APAC Biomarker Testing Market Size by Region (2017-2022) & ($ Millions)
Table 29. APAC Biomarker Testing Market Size Market Share by Region (2017-2022)
Table 30. APAC Biomarker Testing Market Size by Type (2017-2022) & ($ Millions)
Table 31. APAC Biomarker Testing Market Size Market Share by Type (2017-2022)
Table 32. APAC Biomarker Testing Market Size by Application (2017-2022) & ($ Millions)
Table 33. APAC Biomarker Testing Market Size Market Share by Application (2017-2022)
Table 34. Europe Biomarker Testing Market Size by Country (2017-2022) & ($ Millions)
Table 35. Europe Biomarker Testing Market Size Market Share by Country (2017-2022)
Table 36. Europe Biomarker Testing Market Size by Type (2017-2022) & ($ Millions)
Table 37. Europe Biomarker Testing Market Size Market Share by Type (2017-2022)
Table 38. Europe Biomarker Testing Market Size by Application (2017-2022) & ($ Millions)
Table 39. Europe Biomarker Testing Market Size Market Share by Application (2017-2022)
Table 40. Middle East & Africa Biomarker Testing Market Size by Region (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Biomarker Testing Market Size Market Share by Region (2017-2022)
Table 42. Middle East & Africa Biomarker Testing Market Size by Type (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Biomarker Testing Market Size Market Share by Type (2017-2022)
Table 44. Middle East & Africa Biomarker Testing Market Size by Application (2017-2022) & ($ Millions)
Table 45. Middle East & Africa Biomarker Testing Market Size Market Share by Application (2017-2022)
Table 46. Key Market Drivers & Growth Opportunities of Biomarker Testing
Table 47. Key Market Challenges & Risks of Biomarker Testing
Table 48. Key Industry Trends of Biomarker Testing
Table 49. Global Biomarker Testing Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 50. Global Biomarker Testing Market Size Market Share Forecast by Regions (2023-2028)
Table 51. Global Biomarker Testing Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 52. Global Biomarker Testing Market Size Market Share Forecast by Type (2023-2028)
Table 53. Global Biomarker Testing Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 54. Global Biomarker Testing Market Size Market Share Forecast by Application (2023-2028)
Table 55. Agilent Technologies Details, Company Type, Biomarker Testing Area Served and Its Competitors
Table 56. Agilent Technologies Biomarker Testing Product Offered
Table 57. Agilent Technologies Biomarker Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 58. Agilent Technologies Main Business
Table 59. Agilent Technologies Latest Developments
Table 60. Roche Details, Company Type, Biomarker Testing Area Served and Its Competitors
Table 61. Roche Biomarker Testing Product Offered
Table 62. Roche Main Business
Table 63. Roche Biomarker Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 64. Roche Latest Developments
List of Figures
Figure 1. Biomarker Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biomarker Testing Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Biomarker Testing Market Size Market Share by Type in 2021
Figure 7. Biomarker Testing in Hospital
Figure 8. Global Biomarker Testing Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Biomarker Testing in Diagnostic Center
Figure 10. Global Biomarker Testing Market: Diagnostic Center (2017-2022) & ($ Millions)
Figure 11. Biomarker Testing in Others
Figure 12. Global Biomarker Testing Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Biomarker Testing Market Size Market Share by Application in 2021
Figure 14. Global Biomarker Testing Revenue Market Share by Player in 2021
Figure 15. Global Biomarker Testing Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Biomarker Testing Market Size 2017-2022 ($ Millions)
Figure 17. APAC Biomarker Testing Market Size 2017-2022 ($ Millions)
Figure 18. Europe Biomarker Testing Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Biomarker Testing Market Size 2017-2022 ($ Millions)
Figure 20. Americas Biomarker Testing Value Market Share by Country in 2021
Figure 21. Americas Biomarker Testing Consumption Market Share by Type in 2021
Figure 22. Americas Biomarker Testing Market Size Market Share by Application in 2021
Figure 23. United States Biomarker Testing Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Biomarker Testing Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Biomarker Testing Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Biomarker Testing Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Biomarker Testing Market Size Market Share by Region in 2021
Figure 28. APAC Biomarker Testing Market Size Market Share by Application in 2021
Figure 29. China Biomarker Testing Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Biomarker Testing Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Biomarker Testing Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Biomarker Testing Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Biomarker Testing Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Biomarker Testing Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Biomarker Testing Market Size Market Share by Country in 2021
Figure 36. Europe Biomarker Testing Market Size Market Share by Type in 2021
Figure 37. Europe Biomarker Testing Market Size Market Share by Application in 2021
Figure 38. Germany Biomarker Testing Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Biomarker Testing Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Biomarker Testing Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Biomarker Testing Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Biomarker Testing Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Biomarker Testing Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Biomarker Testing Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Biomarker Testing Market Size Market Share by Application in 2021
Figure 46. Egypt Biomarker Testing Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Biomarker Testing Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Biomarker Testing Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Biomarker Testing Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Biomarker Testing Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 52. APAC Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 53. Europe Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 55. United States Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 56. Canada Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 59. China Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 60. Japan Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 61. Korea Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 63. India Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 64. Australia Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 65. Germany Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 66. France Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 67. UK Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 68. Italy Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 69. Russia Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 70. Spain Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 73. Israel Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Biomarker Testing Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
